BioCentury | Jul 22, 2020
Management Tracks

Meeker expands role at Rhythm; plus Biogen, Kronos, Citryll, Akcea, ImmunoGen, Circle, Antares and more

...Alex Monteith as SVP and CBO. He was VP of business development at Deerfield Management. Cradle Genomics...
...orphan lung diseases. Robin Sawka, BioCentury Staff Biogen Inc. Kronos Bio Inc. ImmunoGen Inc. Antares Pharma Inc. Krystal Biotech Inc. BioSpecifics Technologies Corp. Cradle Genomics MannKind...
BioCentury | Jul 16, 2019
Financial News

July 16 Financial Quick Takes: J&J growth drivers beat consensus; plus Notable and Cradle raise funds

...in the round. Illumina, Section 32 lead Cradle Genomics' $17M series A Non-invasive prenatal testing company Cradle Genomics...
...Ventures, Listwin Ventures and Axon Ventures also participated. Consensus figures provided by FactSet. Paul Bonanos, Associate Editor Cradle Genomics daratumumab Darzalex Genmab...
Items per page:
1 - 2 of 2
BioCentury | Jul 22, 2020
Management Tracks

Meeker expands role at Rhythm; plus Biogen, Kronos, Citryll, Akcea, ImmunoGen, Circle, Antares and more

...Alex Monteith as SVP and CBO. He was VP of business development at Deerfield Management. Cradle Genomics...
...orphan lung diseases. Robin Sawka, BioCentury Staff Biogen Inc. Kronos Bio Inc. ImmunoGen Inc. Antares Pharma Inc. Krystal Biotech Inc. BioSpecifics Technologies Corp. Cradle Genomics MannKind...
BioCentury | Jul 16, 2019
Financial News

July 16 Financial Quick Takes: J&J growth drivers beat consensus; plus Notable and Cradle raise funds

...in the round. Illumina, Section 32 lead Cradle Genomics' $17M series A Non-invasive prenatal testing company Cradle Genomics...
...Ventures, Listwin Ventures and Axon Ventures also participated. Consensus figures provided by FactSet. Paul Bonanos, Associate Editor Cradle Genomics daratumumab Darzalex Genmab...
Items per page:
1 - 2 of 2